Care for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Fibromyalgia, and or Multiple Chemical Sensitivities (MCS)? It is still over the horizon and a large number of people are waiting for something that might not ever be made available to them. Many people have waited decades for treatments that have yet to materialize. The future is far away.

working to improve care for people living with:

ME/CFS myalgic encephalomyelitis/chronic fatigue syndrome

FM fibromyalgia

ES/MCS environmental sensitivities/multiple chemical sensitivities

CareNow Ontario Objects

By Supplementary Letters Patent of November, 2020 and revised on Oct. 12, 2022, CareNow Ontario’s (formerly MEAO) new Objects are:

To improve care, treatment and support of individuals in Ontario who are living with complex, chronic, environmentally-linked medical conditions, focused on, but not limited to, myalgic encehpalomyelitis/chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), and environmental sensitivities/multiple chemical sensitivity (ES/MCS), by:

  1. Providing support to individuals, their families and caregivers, such as, publishing newsletters and maintaining website(s) with current information about the relevant conditions; and
  2. Working with relevant government and public agencies, health and social services agencies and other professionals, the media and the public